共 50 条
- [21] Phospho-STAT1 expression as a potential biomarker for anti-PD-1/anti-PD-L1 immunotherapy for breast cancerINTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (06) : 2030 - 2038Nakayama, YukoMimura, KosakuTamaki, TomoakiShiraishi, KensukeKua, Ley-FangKoh, VivienOhmori, MasatoKimura, AyakoInoue, ShingoOkayama, HirokazuSuzuki, YoshiyukiNakazawa, TadaoIchikawa, DaisukeKono, Koji
- [22] Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitorsMOLECULAR ONCOLOGY, 2024,Hernandez-Prat, AnnaRodriguez-Vida, AlejoCardona, LauraQin, MengjuanArpi-Llucia, OriolSoria-Jimenez, LuisMenendez, SilviaQuimis, Fabricio GerelGalindo, MiguelArriola, EdurneSalido, MartaJuanpere-Rodero, NuriaRojo, FedericoMuntasell, AuraAlbanell, JoanRovira, AnaBellmunt, Joaquim
- [23] Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodiesINTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 39 - 46Philips, George K.Atkins, Michael
- [24] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanomaMELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50Simeone, EsterGrimaldi, Antonio M.Ascierto, Paolo A.
- [25] Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapyCANCER RESEARCH, 2023, 84 (06)Yi, BinMa, RuixiaXi, Yaguang
- [26] Anti-PD-L1 Immunotherapy Enhances Radiation-induced Abscopal Response in GlioblastomaJOURNAL OF NEUROSURGERY, 2019, 131 (01)Ene, ChibawanyeKreuser, ShannonJung, MiyeonParney, IanCrane, CourtneyHolland, Eric
- [27] Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapyJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):Liu, HaoZhao, ZhenZhang, LiLi, YuankeJain, AkshayBarve, AshutoshJin, WeiLiu, YanliFetse, JohnCheng, Kun
- [28] Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 ImmunotherapyMOLECULAR CANCER THERAPEUTICS, 2021, 20 (07) : 1295 - 1304Yi, BinCheng, HaoWyczechowska, DorotaYu, QingzhaoLi LiOchoa, Augusto C.Riker, Adam, IXi, Yaguang
- [29] In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?EUROPEAN JOURNAL OF CANCER, 2017, 87 : 65 - 74Aspeslagh, SandrineMatias, MargaridaPalomar, VirginiaDercle, LaurentLanoy, EmilieSoria, Jean-CharlesPostel-Vinay, Sophie
- [30] Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1 /PD-1 immunotherapyBLOOD, 2021, 137 (02) : 216 - 231Ioannou, NikolaosHagner, Patrick R.Stokes, MattGandhi, Anita K.Apollonio, BenedettaFanous, MariamPapazoglou, DespoinaSutton, Lesley-AnnRosenquist, RichardAmini, Rose-MarieChiu, HsilingLopez-Girona, AntoniaJanardhanan, PreethiAwan, Farrukh T.Jones, JeffreyKay, Neil E.Shanafelt, Tait D.Tallman, Martin S.Stamatopoulos, KostasPatten, Piers E. M.Vardi, AnnaRamsay, Alan G.